Skip to main content
English
中文
Log In
Log in
Log in with ORCID
NTU Single Sign On
Have you forgotten your password?
Home
College of Medicine / 醫學院
School of Medicine / 醫學系
Pegylated Liposomal Doxorubicin as Adjuvant Therapy for Stage I-III Operable Breast Cancer
Details
Pegylated Liposomal Doxorubicin as Adjuvant Therapy for Stage I-III Operable Breast Cancer
Journal
In vivo (Athens, Greece)
Journal Volume
30
Journal Issue
2
Pages
159-163
Date Issued
2016
Author(s)
Lu Y.-C.
Ou-Yang F.U.
Hsieh C.-M.
KING-JEN CHANG
Chen D.-R.
Tu C.-W.
Wang H.-C.
Hou M.-F.
URI
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85010010600&partnerID=40&md5=8da75e6412f3de4c943052d79a05c50a
https://scholars.lib.ntu.edu.tw/handle/123456789/616617
Type
journal article